| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.048 | 0.8 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |